Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Alkermes To Acquire Avadel Pharmaceuticals Plc (NASDAQ: AVDL) In $2.1 Billion All-Cash Deal Including CVR Worth Up To $20 Per Share

Author: Benzinga Newsdesk | October 22, 2025 06:14am

Posted In: ALKS AVDL